Angioimmunoblastic Lymphadenopathy With Dysproteinemia

Posted 3 weeks ago by Wales Gene Park

The purpose of this study is to test the safety and efficacy of AUTO4 a CAR T cell treatment targeting TRBC1 in patients with relapsed or refractory TRBC1 positive selected T-Non-Hodgkin Lymphoma.

 Angioimmunoblastic Lymphadenopathy With Dysproteinemia


No post found